Source: Geelong Advertiser

Atomo Diagnostics: Atomo raises capital for US pregnancy test launch

ASX-listed diagnostics company Atomo plans to release its blood-based rapid pregnancy test in Australia by the end of the year and in the US within the next 18 months as it pivots from Covid-19.

Read full article »

Atomo Diagnostics's Competitors | Atomo Diagnostics's News | Atomo Diagnostics's Financials

Followers on Owler

Annual Revenue

$5.0-25M

Employees

25-100

Founder & CEO

John Kelly

CEO Approval Rating

77/100

Atomo Diagnostics is an Australia-based company that designs, manufactures, and commercializes in-vitro diagnostic products for the healthcare sector.